药品注册申请号:019781
申请类型:NDA (新药申请)
申请人:VIRTUS
申请人全名:VIRTUS PHARMACEUTICALS LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 PROMETRIUM PROGESTERONE CAPSULE;ORAL 100MG Yes No AB 1998/05/14 1998/05/14 Prescription
002 PROMETRIUM PROGESTERONE CAPSULE;ORAL 200MG Yes Yes AB 1999/10/15 Prescription
003 PROMETRIUM PROGESTERONE CAPSULE;ORAL 300MG No No None 1999/10/15 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/02/15 SUPPL-25(补充) Approval Labeling STANDARD
2020/11/18 SUPPL-22(补充) Approval Manufacturing (CMC) N/A
2014/09/30 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
2014/08/13 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
2013/04/19 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
2011/11/01 SUPPL-17(补充) Approval Labeling UNKNOWN
2009/06/30 SUPPL-13(补充) Approval Labeling STANDARD
2004/12/10 SUPPL-6(补充) Approval Labeling STANDARD
2004/12/10 SUPPL-5(补充) Approval Labeling STANDARD
2004/03/04 SUPPL-8(补充) Approval Labeling STANDARD
2002/03/01 SUPPL-7(补充) Approval Manufacturing (CMC) STANDARD
2000/04/17 SUPPL-4(补充) Approval Manufacturing (CMC) STANDARD
2000/04/17 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
2000/04/17 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1999/10/15 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1998/05/14 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PROGESTERONE 剂型/给药途径:CAPSULE;ORAL 规格:100MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019781 001 NDA PROMETRIUM PROGESTERONE CAPSULE;ORAL 100MG Prescription Yes No AB 1998/05/14 VIRTUS
200456 001 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 100MG Prescription No No AB 2012/09/28 SOFGEN PHARMS
200900 001 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 100MG Prescription No No AB 2013/08/16 BIONPHARMA
208801 001 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 100MG Prescription No No AB 2017/02/28 DR REDDYS
207724 001 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 100MG Prescription No No AB 2017/09/07 AMNEAL PHARMS NY
205229 001 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 100MG Prescription No No AB 2017/10/20 XIROMED
211285 001 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 100MG Prescription No No AB 2018/10/26 EUGIA PHARMA
活性成分:PROGESTERONE 剂型/给药途径:CAPSULE;ORAL 规格:200MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019781 002 NDA PROMETRIUM PROGESTERONE CAPSULE;ORAL 200MG Prescription Yes Yes AB 1999/10/15 VIRTUS
200456 002 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 200MG Prescription No No AB 2012/09/28 SOFGEN PHARMS
200900 002 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 200MG Prescription No No AB 2013/08/16 BIONPHARMA
208801 002 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 200MG Prescription No No AB 2017/02/28 DR REDDYS
207724 002 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 200MG Prescription No No AB 2017/09/07 AMNEAL PHARMS NY
205229 002 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 200MG Prescription No No AB 2017/10/20 XIROMED
211285 002 ANDA PROGESTERONE PROGESTERONE CAPSULE;ORAL 200MG Prescription No No AB 2018/10/26 EUGIA PHARMA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database